The influence of systemic glucocorticoid therapy upon the risk of non-serious infection in older patients with rheumatoid arthritis: a nested case-control study.
about
Hepatitis B Reactivation During Immunosuppressive Therapy or Cancer Chemotherapy, Management, and Prevention: A Comprehensive Review-ScreenedCommon Infections in Patients Prescribed Systemic Glucocorticoids in Primary Care: A Population-Based Cohort StudyRisk and prognosis of adult primary immune thrombocytopenia.Corticosteroid Risk Function of Severe Infection in Primary Immune Thrombocytopenia Adults. A Nationwide Nested Case-Control Study.Infections in non-splenectomized persistent or chronic primary immune thrombocytopenia adults: risk factors and vaccination effect.Association of baseline steroid use with long-term rates of infection and sepsis in the REGARDS cohortThe value of glucocorticoid co-therapy in different rheumatic diseases--positive and adverse effectsInfection and Lupus: Which Causes Which?Steroid-Based Therapy and Risk of Infectious Complications.Immediate and delayed impact of oral glucocorticoid therapy on risk of serious infection in older patients with rheumatoid arthritis: a nested case-control analysisHepatitis B Serology in Patients with Rheumatic DiseasesInfection risk in rheumatoid arthritis and spondyloarthropathy patients under treatment with DMARDs, corticosteroids and TNF-α antagonists.Glucocorticoid use and abuse in SLE.Infectious complications in juvenile idiopathic arthritis.Infection risk in systemic lupus erythematosus patients: susceptibility factors and preventive strategies.Rheumatoid arthritis in the elderly in the era of tight control.Safety of synthetic and biological DMARDs: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis.Long-term safety of immunomodulators in pediatric inflammatory diseases.Hepatitis B and immunosuppressive therapies for chronic inflammatory diseases: When and how to apply prophylaxis, with a special focus on corticosteroid therapy.Screening and vaccinations in patients requiring systemic immunosuppression: an update for dermatologists.Optimizing perioperative outcomes for older patients with rheumatoid arthritis undergoing arthroplasty: emphasis on medication management.A Pilot Placebo Controlled Randomized Trial of Dexamethasone for Chronic Subdural Hematoma.Hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients receiving immunosuppressive therapy for glomerulonephritis: a retrospective analysis.The association between serious infection and disease outcome in patients with rheumatoid arthritis.Investigation of the effect of phlomisoside F on complete Freund's adjuvant-induced arthritis.Infections and systemic lupus erythematosus.Tocilizumab induces corticosteroid sparing in rheumatoid arthritis patients in clinical practice.Serious infections in a population-based cohort of 86,039 seniors with rheumatoid arthritis.Tumour necrosis factor inhibitor therapy and infection risk in axial spondyloarthritis: results from a longitudinal observational cohort.Glucocorticoids in the treatment of rheumatoid arthritis: still used after 65 years.[Systematic literature research for S1 guidelines on sequential medical treatment of rheumatoid arthritis].
P2860
Q28076703-F436096C-CBB9-45A6-BB59-05E1F4D73934Q28602277-8D5A5E99-1741-43DA-8F7E-0594BA26A365Q33400566-E25DEFC1-4361-4CA1-B9A6-413A8FF0F520Q33427488-47759EA3-8992-4E7B-BB91-831E12616F49Q33438334-F7DB4754-D2EF-48E6-8A9A-D07B28E44D5FQ33901429-5F9C3AEC-7B0B-4E83-BB12-481B1E7BA261Q34597321-129CAFF3-4CEC-41E2-ACC5-E531168D8530Q35948285-2DFCE31D-29FD-4C42-BE27-652114168CDBQ36027748-EE256F21-FCCE-4AAD-8E21-2AF557B6F639Q36033348-795507DB-C9D1-47C1-B7F0-CFDE8A3A797BQ37291847-2234658F-E866-47E4-A486-6ECB009CDC79Q37714705-ACEEDA86-A77C-4BFA-BB10-B2A6A0D934FAQ37978291-F8E9CA0B-A6E4-4E49-AB9A-FDD20A78F0D7Q38093095-C68EB1CD-B4ED-42FE-9EC2-53B68B433EDDQ38149856-8FB5858A-A551-4B79-A6AB-C9DC63D9A91DQ38150731-9C6FA7AC-BFD5-4256-A955-6210A3E94D14Q38176745-023B9350-3AF4-4375-9AE7-89EA82BDCC94Q38232338-C57B67FC-19B9-46A8-B0A5-7D6B0C6C17ECQ38408897-790AB6AE-08E4-4F73-B5DD-D81256C30896Q38411930-3BDB330B-4F6F-4FBF-B108-4FE20ABC5157Q38458992-106F242C-6D63-424F-8371-1A0E6ECADADCQ40016634-D453E9E2-171A-42B5-B4E7-BB93A46C5880Q40403588-67161F81-C901-4102-B48A-BB9AB447C93BQ40868036-187F5D62-5566-42B5-A646-151BA45C7626Q41980702-DA3C070E-BEC0-40A4-A182-6F15917E4154Q42220143-BF8D7BE8-7B09-4B8F-B600-948947657ED5Q42684613-1E5243A8-A23E-454F-8604-8C3A55110F66Q44710851-77999938-4C08-4E06-9175-ECF896E4105FQ45840259-E72E8CE0-B557-44E2-965D-1B8D3652D860Q51747688-2EFA5921-CD0E-4D48-8257-839B03EC6C3BQ52887079-B81DDA41-6EE4-4F37-86C2-8C74A922BA55
P2860
The influence of systemic glucocorticoid therapy upon the risk of non-serious infection in older patients with rheumatoid arthritis: a nested case-control study.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The influence of systemic gluc ...... : a nested case-control study.
@ast
The influence of systemic gluc ...... : a nested case-control study.
@en
The influence of systemic gluc ...... : a nested case-control study.
@nl
type
label
The influence of systemic gluc ...... : a nested case-control study.
@ast
The influence of systemic gluc ...... : a nested case-control study.
@en
The influence of systemic gluc ...... : a nested case-control study.
@nl
prefLabel
The influence of systemic gluc ...... : a nested case-control study.
@ast
The influence of systemic gluc ...... : a nested case-control study.
@en
The influence of systemic gluc ...... : a nested case-control study.
@nl
P2093
P2860
P356
P1476
The influence of systemic gluc ...... : a nested case-control study.
@en
P2093
P2860
P304
P356
10.1136/ARD.2010.144741
P407
P577
2011-02-01T00:00:00Z